Cargando…

Changes in risk factors and their contribution to reduction of mortality risk following gastric bypass surgery among obese individuals with type 2 diabetes: a nationwide, matched, observational cohort study

OBJECTIVE: We recently showed that Roux-en-Y gastric bypass (RYGB) reduces risks of mortality, cardiovascular death and myocardial infarction in obese individuals compared with matched patients with diabetes mellitus (DM). We have examined changes in risk factors after RYGB, with the aim of explaini...

Descripción completa

Detalles Bibliográficos
Autores principales: Liakopoulos, Vasileios, Franzén, Stefan, Svensson, Ann-Marie, Zethelius, Björn, Ottosson, Johan, Näslund, Ingmar, Gudbjörnsdottir, Soffia, Eliasson, Björn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530233/
https://www.ncbi.nlm.nih.gov/pubmed/28761655
http://dx.doi.org/10.1136/bmjdrc-2016-000386
_version_ 1783253237912043520
author Liakopoulos, Vasileios
Franzén, Stefan
Svensson, Ann-Marie
Zethelius, Björn
Ottosson, Johan
Näslund, Ingmar
Gudbjörnsdottir, Soffia
Eliasson, Björn
author_facet Liakopoulos, Vasileios
Franzén, Stefan
Svensson, Ann-Marie
Zethelius, Björn
Ottosson, Johan
Näslund, Ingmar
Gudbjörnsdottir, Soffia
Eliasson, Björn
author_sort Liakopoulos, Vasileios
collection PubMed
description OBJECTIVE: We recently showed that Roux-en-Y gastric bypass (RYGB) reduces risks of mortality, cardiovascular death and myocardial infarction in obese individuals compared with matched patients with diabetes mellitus (DM). We have examined changes in risk factors after RYGB, with the aim of explaining these effects. RESEARCH DESIGN AND METHODS: We matched (1:1) 6132 RYGB patients with DM reported to the Scandinavian Obesity Surgery Register with patients who had not undergone RYGB, based on sex, age, body mass index (BMI) and time, and assessed effects 2007–2014. We used causal mediation analysis to study effects mediated through changes to BMI and risk factors at 1 year based on Cox proportional hazards models. RESULTS: Baseline BMI was 42 kg/m(2). Following RYGB, the lowest BMI was observed after 2 years (mean 31.9 kg/m(2)), and hemoglobin A1c (HbA1c) after 1 year (mean 6.32% (45.6 mmol/mol)). Maximum high-density lipoprotein (HDL) cholesterol was observed after 3–5 years (mean 1.46 mmol/L). Differences in BMI, HbA1c and HDL between the groups were statistically significant up to 6 years, and 2–3 years for low-density lipoprotein (LDL) and blood pressure, despite fewer glucose-lowering, hypertensive and lipid-lowering treatments. The causal mediation analysis suggested that RYGB has a positive effect on mortality risk, mainly by means of weight reduction (as opposed to changes to the risk factors analyzed). CONCLUSIONS: Improvements in risk factors might contribute to the reduction of mortality risk after RYGB in obese individuals with type 2 diabetes, but the main effect seems to be mediated through a decrease in BMI, which could serve as a proxy for several mechanisms.
format Online
Article
Text
id pubmed-5530233
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-55302332017-07-31 Changes in risk factors and their contribution to reduction of mortality risk following gastric bypass surgery among obese individuals with type 2 diabetes: a nationwide, matched, observational cohort study Liakopoulos, Vasileios Franzén, Stefan Svensson, Ann-Marie Zethelius, Björn Ottosson, Johan Näslund, Ingmar Gudbjörnsdottir, Soffia Eliasson, Björn BMJ Open Diabetes Res Care Obesity Studies OBJECTIVE: We recently showed that Roux-en-Y gastric bypass (RYGB) reduces risks of mortality, cardiovascular death and myocardial infarction in obese individuals compared with matched patients with diabetes mellitus (DM). We have examined changes in risk factors after RYGB, with the aim of explaining these effects. RESEARCH DESIGN AND METHODS: We matched (1:1) 6132 RYGB patients with DM reported to the Scandinavian Obesity Surgery Register with patients who had not undergone RYGB, based on sex, age, body mass index (BMI) and time, and assessed effects 2007–2014. We used causal mediation analysis to study effects mediated through changes to BMI and risk factors at 1 year based on Cox proportional hazards models. RESULTS: Baseline BMI was 42 kg/m(2). Following RYGB, the lowest BMI was observed after 2 years (mean 31.9 kg/m(2)), and hemoglobin A1c (HbA1c) after 1 year (mean 6.32% (45.6 mmol/mol)). Maximum high-density lipoprotein (HDL) cholesterol was observed after 3–5 years (mean 1.46 mmol/L). Differences in BMI, HbA1c and HDL between the groups were statistically significant up to 6 years, and 2–3 years for low-density lipoprotein (LDL) and blood pressure, despite fewer glucose-lowering, hypertensive and lipid-lowering treatments. The causal mediation analysis suggested that RYGB has a positive effect on mortality risk, mainly by means of weight reduction (as opposed to changes to the risk factors analyzed). CONCLUSIONS: Improvements in risk factors might contribute to the reduction of mortality risk after RYGB in obese individuals with type 2 diabetes, but the main effect seems to be mediated through a decrease in BMI, which could serve as a proxy for several mechanisms. BMJ Publishing Group 2017-06-14 /pmc/articles/PMC5530233/ /pubmed/28761655 http://dx.doi.org/10.1136/bmjdrc-2016-000386 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Obesity Studies
Liakopoulos, Vasileios
Franzén, Stefan
Svensson, Ann-Marie
Zethelius, Björn
Ottosson, Johan
Näslund, Ingmar
Gudbjörnsdottir, Soffia
Eliasson, Björn
Changes in risk factors and their contribution to reduction of mortality risk following gastric bypass surgery among obese individuals with type 2 diabetes: a nationwide, matched, observational cohort study
title Changes in risk factors and their contribution to reduction of mortality risk following gastric bypass surgery among obese individuals with type 2 diabetes: a nationwide, matched, observational cohort study
title_full Changes in risk factors and their contribution to reduction of mortality risk following gastric bypass surgery among obese individuals with type 2 diabetes: a nationwide, matched, observational cohort study
title_fullStr Changes in risk factors and their contribution to reduction of mortality risk following gastric bypass surgery among obese individuals with type 2 diabetes: a nationwide, matched, observational cohort study
title_full_unstemmed Changes in risk factors and their contribution to reduction of mortality risk following gastric bypass surgery among obese individuals with type 2 diabetes: a nationwide, matched, observational cohort study
title_short Changes in risk factors and their contribution to reduction of mortality risk following gastric bypass surgery among obese individuals with type 2 diabetes: a nationwide, matched, observational cohort study
title_sort changes in risk factors and their contribution to reduction of mortality risk following gastric bypass surgery among obese individuals with type 2 diabetes: a nationwide, matched, observational cohort study
topic Obesity Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530233/
https://www.ncbi.nlm.nih.gov/pubmed/28761655
http://dx.doi.org/10.1136/bmjdrc-2016-000386
work_keys_str_mv AT liakopoulosvasileios changesinriskfactorsandtheircontributiontoreductionofmortalityriskfollowinggastricbypasssurgeryamongobeseindividualswithtype2diabetesanationwidematchedobservationalcohortstudy
AT franzenstefan changesinriskfactorsandtheircontributiontoreductionofmortalityriskfollowinggastricbypasssurgeryamongobeseindividualswithtype2diabetesanationwidematchedobservationalcohortstudy
AT svenssonannmarie changesinriskfactorsandtheircontributiontoreductionofmortalityriskfollowinggastricbypasssurgeryamongobeseindividualswithtype2diabetesanationwidematchedobservationalcohortstudy
AT zetheliusbjorn changesinriskfactorsandtheircontributiontoreductionofmortalityriskfollowinggastricbypasssurgeryamongobeseindividualswithtype2diabetesanationwidematchedobservationalcohortstudy
AT ottossonjohan changesinriskfactorsandtheircontributiontoreductionofmortalityriskfollowinggastricbypasssurgeryamongobeseindividualswithtype2diabetesanationwidematchedobservationalcohortstudy
AT naslundingmar changesinriskfactorsandtheircontributiontoreductionofmortalityriskfollowinggastricbypasssurgeryamongobeseindividualswithtype2diabetesanationwidematchedobservationalcohortstudy
AT gudbjornsdottirsoffia changesinriskfactorsandtheircontributiontoreductionofmortalityriskfollowinggastricbypasssurgeryamongobeseindividualswithtype2diabetesanationwidematchedobservationalcohortstudy
AT eliassonbjorn changesinriskfactorsandtheircontributiontoreductionofmortalityriskfollowinggastricbypasssurgeryamongobeseindividualswithtype2diabetesanationwidematchedobservationalcohortstudy